乙胺作为急性失偿心力衰竭患者的辅助利尿疗法:系统性审查和元分析
Ahmed Kamal Siddiqi1, Muhammad Talha Maniya1, Muhammad Tanveer Alam2
1Department of Medicine, Ziauddin Medical University, Karachi, Pakistan.
概括
乙胺作为一种附加的利尿剂显著增强了急性不补偿性心力衰竭患者的尿,尿液输出和脱血. 然而,它并没有改善体积过载的个体症状,如胀或.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 最近的证据表明,在急性不补偿性心力衰竭 (ADHF) 中,乙醇胺作为辅助性利尿疗法的好处.
- 本系统性审查旨在巩固关于乙醇胺在ADHF中有效性的证据.
- 该审查在PROSPERO (CRD498330) 上进行了前性注册.
研究的目的:
- 系统地审查和元分析关于乙醇胺作为ADHF辅助利尿剂的有效性的现有证据.
- 评估乙醇胺对自然尿的影响,尿液产量和塞的临床迹象.
- 用GRADE方法评估证据的整体确定性.
主要方法:
- 在PubMed/Medline,Cochrane图书馆和Scopus进行了全面的文献搜索,直到2023年7月.
- 包括随机和非随机研究,评估阿西塔佐拉米德作为ADHF患者的附加性利尿疗法.
- 用随机效应模型汇集了自然尿量,尿量和脱血标记的数据,结果呈现为风险比率,赔率比率或加权平均差异.
主要成果:
- 对5项研究的综合分析 (n=684) 显示,使用乙胺显著增加了性尿量 (MD 55.07) 和尿量 (MD 1.04).
- 高确定性证据表明,在乙醇胺组中改善了脱 (OR 1.62).
- 两组之间没有观察到,,关静脉压力或肺病的显著差异.
结论:
- 乙醇胺作为辅助利尿剂显著改善了ADHF脱血治疗的全球代用终点.
- 它并不能始终改善所有单个体积过载的迹象和症状.
- 进一步的研究可能会澄清其在管理特定临床表现方面的作用.
更多相关视频
07:59Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
Published on: July 28, 2018
11.2K
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
1.8K
相关概念视频
01:22Heart Failure Drugs: Diuretics
375
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
375
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
632
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
632
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
545
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
545
01:16Antihypertensive Drugs: Action of Diuretics
690
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
690
01:26Heart Failure Drugs: Inotropic Agents
586
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
586